antifungal therapy – Page 17

Invasive Candidiasis in Contexts of Armed Conflict, High Violence, and Forced Displacement in Latin America and the Caribbean (2005–2025)

mycolabadmin

Invasive candidiasis, a serious fungal blood infection caused by Candida species, is a major health crisis in Latin America and the Caribbean with death rates reaching 60% in vulnerable populations. The disease is worsening in areas affected by armed conflict, violence, and displacement where poor living conditions, overcrowding, malnutrition, and lack of healthcare create ideal conditions for the infection to develop and spread. Antifungal drugs are often unavailable or too expensive, and drug-resistant strains of Candida are becoming increasingly common, making treatment extremely challenging in these regions.

Ex Vivo Host Transcriptomics During Cryptococcus neoformans, Cryptococcus gattii, and Candida albicans Infection of Peripheral Blood Mononuclear Cells From South African Volunteers

mycolabadmin

Researchers studied how human immune cells respond to three different fungal infections that commonly affect people with weakened immune systems. By examining gene activity in blood cells exposed to these fungi, they discovered that each fungus triggers different immune responses, with Candida albicans causing a much stronger reaction than the two Cryptococcus species. Only one shared immune pathway was activated by all three fungi, suggesting each infection requires different immune mechanisms to fight off. These findings could help develop new treatments for serious fungal infections.

Fungal peritonitis in a patient on peritoneal dialysis caused by Hyphopichia burtonii: A rare pathogen in human infection

mycolabadmin

A woman with kidney disease on peritoneal dialysis developed an unusual fungal infection caused by Hyphopichia burtonii, a fungus typically found in spoiled food. The infection was diagnosed using advanced protein analysis technology and treated with antifungal medication after removing the dialysis catheter. Though extremely rare in humans, this case shows that unusual fungi can cause serious infections in patients with weakened immune systems and highlights the importance of considering these organisms when standard treatments don’t work.

The first report of rhinosinusitis by Rhizopus delemar in a patient with severe COVID-19 in Iran: a case report

mycolabadmin

A 63-year-old man hospitalized with COVID-19 developed a serious fungal sinus infection caused by a rare mold called Rhizopus delemar. Despite surgery to remove infected tissue and treatment with antifungal medication amphotericin B, the infection spread and the patient died after five weeks. This was the first documented case of this particular mold causing sinus infection in a COVID-19 patient in Iran, highlighting how severe fungal infections can occur as dangerous complications of COVID-19.

Protoplast-mediated transformation of Madurella mycetomatis using hygromycin resistance as a selection marker

mycolabadmin

Scientists have successfully developed a genetic engineering method for Madurella mycetomatis, the fungus that causes mycetoma, a serious tropical disease. They used a technique to remove the fungal cell wall and insert genes into the cells, creating strains that produce green fluorescent protein (GFP). This breakthrough enables researchers to better understand how this fungus causes disease and to develop new treatments.

Staurosporine as an Antifungal Agent

mycolabadmin

Staurosporine is a natural compound produced by soil bacteria that can kill fungi. Scientists originally discovered it in 1977 and found it works by blocking proteins called kinases that fungi need to survive. Recent research shows it could be useful against drug-resistant fungal infections, especially when combined with other antifungal medicines. However, it needs to be modified to make it safer for human use.

Acute fungal endometritis in women with abnormal uterine bleeding: Clinical and microbiological insights

mycolabadmin

This study examined a rare fungal infection of the uterus called fungal endometritis that causes abnormal bleeding and discomfort in women. Researchers found that about 12% of women with unexplained abnormal bleeding had this fungal infection, which was caused by different species of Candida yeast. A simple test using vaginal swabs was not effective for diagnosis; instead, doctors needed to take samples directly from the uterine lining. Treatment with an antifungal medication called voriconazole combined with surgical cleaning was successful in all cases studied.

Invasive fungal infections caused by rare yeast-like fungi in adult patients: results of a prospective study

mycolabadmin

This study examined rare fungal infections in 30 critically ill adult patients over 18 years, finding that infections caused by uncommon yeasts like Trichosporon and Rhodotorula affected mainly long-term ICU patients with central lines. Despite treatment with antifungal medications, about 37% of patients died, highlighting the serious nature of these infections. The research emphasizes the importance of quickly identifying the specific fungus causing infection and using appropriate medications, along with removing infected catheters, to improve patient survival.

Spectrum of Fungal Infections in Continuous Ambulatory Peritoneal Dialysis: A 20-Year Retrospective Study From a Tertiary Care Center

mycolabadmin

This study examined fungal infections in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) over 20 years at an Indian medical center. Researchers found that yeast infections, particularly Candida tropicalis, were more common than mold infections, with Aspergillus flavus being the most frequent mold. The study identified several rare and emerging fungi causing these serious infections and tested their susceptibility to antifungal medications. Results show that removing the dialysis catheter combined with appropriate antifungal treatment is crucial for patient survival.

Caspofungin therapy in prosthetic valve endocarditis and candidemia due to itraconazole-resistant Candida glabrata (Nakaseomyces glabratus): A case report

mycolabadmin

A 13-year-old boy developed a serious fungal infection of his heart valve after receiving an artificial valve replacement. The initial antibiotic (itraconazole) did not work because the fungus became resistant, likely by forming a protective biofilm. After identifying the resistant fungus through specialized testing, doctors switched to a different medication called caspofungin. The patient fully recovered with this new treatment and remained healthy during follow-up, showing that combination of precise identification and targeted treatment can overcome antibiotic resistance.

Research Keyword: antifungal therapy